Vera Therapeutics, Inc.VERANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+65.8%
5Y CAGR+91.3%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+65.8%/yr
Annual compound
5Y CAGR
+91.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
25.6x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$99.78M+143.4%
2024$41.00M+72.4%
2023$23.79M+8.6%
2022$21.91M+83.8%
2021$11.92M+206.1%
2020$3.89M-11.7%
2019$4.41M-